EGFR mutation analysis could guide therapy in lung cancer
This article was originally published in Clinica
Executive Summary
A personalised medicine approach could soon be taken to non-small cell lung cancer (NSCLC), as researchers have discovered that patients' genomes determine their responses to certain treatments.